| Dr Sonal Saraiya, MD | |
|
3901 Beaubien St, Detroit, MI 48201-2119 | |
| (313) 745-5402 | |
| Not Available |
| Full Name | Dr Sonal Saraiya |
|---|---|
| Gender | Female |
| Speciality | Otolaryngology - Pediatric Otolaryngology |
| Location | 3901 Beaubien St, Detroit, Michigan |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538399621 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207YP0228X | Otolaryngology - Pediatric Otolaryngology | 4301093304 (Michigan) | Primary |
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
Now, a new study published on the preprint server medRxiv in September 2020 shows that a significant variant characterized by the D614G mutation has higher infectivity, which may account for its rapid rise to the dominant position in all regions where it has emerged.
The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.
NanoLogix, Inc. an innovator in the rapid detection, identification of live bacteria, and determination of their antibiotic resistance and sensitivity, announces that they are working with Nasaem-Aljazira, a Saudi Arabian company headquartered in Riyadh, to establish exclusive distribution and/or manufacturing of NanoLogix products in Saudi Arabia and the Arabian Gulf region, also known as the Gulf Cooperation Council (GCC) area.
On the heels of its successful 2009 campaign, CUTCO Cutlery Corp. has announced it will recommit to the American Heart Association's Go Red For Women® movement for another year.
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Sonal Saraiya, MD 712 Hilldale Dr, Royal Oak, MI 48067-1686 Ph: (201) 281-4709 | Dr Sonal Saraiya, MD 3901 Beaubien St, Detroit, MI 48201-2119 Ph: (313) 745-5402 |
News Archive
Now, a new study published on the preprint server medRxiv in September 2020 shows that a significant variant characterized by the D614G mutation has higher infectivity, which may account for its rapid rise to the dominant position in all regions where it has emerged.
The IDSA Center for Global Health Policy and the HIV Medicine Association recently released a policy statement responding to the results of the HPTN 052 study sponsored by the National Institute of Allergy and Infectious Diseases (NIAID) at NIH, which found that people with HIV who received immediate antiretroviral therapy (ART) were more than 96 percent less likely to sexually transmit the infection to their uninfected partners.
NanoLogix, Inc. an innovator in the rapid detection, identification of live bacteria, and determination of their antibiotic resistance and sensitivity, announces that they are working with Nasaem-Aljazira, a Saudi Arabian company headquartered in Riyadh, to establish exclusive distribution and/or manufacturing of NanoLogix products in Saudi Arabia and the Arabian Gulf region, also known as the Gulf Cooperation Council (GCC) area.
On the heels of its successful 2009 campaign, CUTCO Cutlery Corp. has announced it will recommit to the American Heart Association's Go Red For Women® movement for another year.
Australian drug development company CBio Limited today announced the achievement of a clinical trial milestone under its option agreement with global pharmaceutical leader Novo Nordisk A/S. The agreement relates to the development of XToll, the potential new-generation drug therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis (RA).
› Verified 1 days ago
Dr. Samba Siva Reddy Bathula, M.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 4160 John R St Ste 1007, Dmc Ent-harper Professional Building, Detroit, MI 48201 Phone: 313-966-9471 Fax: 313-966-9470 | |
Dr. Kathleen L. Yaremchuk, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-3275 Fax: 313-916-7263 | |
Dr. Lamont Jones, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Department Of Otolaryngology, Henry Ford Hospital, Detroit, MI 48202 Phone: 313-916-3272 Fax: 313-916-7263 | |
Dr. Joshua Romero, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-2600 | |
Robert Hadi Deeb, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-916-3275 | |
Nathan Gonik, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 3901 Beaubien St, Suite 2102, Detroit, MI 48201 Phone: 313-966-6443 Fax: 313-745-0747 | |
Dr. Ilaaf Darrat, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2799 W Grand Blvd, Detroit, MI 48202 Phone: 313-587-3523 |